AGIC Capital Invests in Eulitha AG
July 5, 2022
AGIC Capital, a European-Asian private equity firm, has made an undisclosed investment into Switzerland-based Eulitha AG to support the company's international expansion and commercialization of its proprietary PHABLE non-contact Nano-UV-lithography systems. The capital will be used to accelerate global growth—particularly in the Asia Pacific region—and scale Eulitha's sales, customers and R&D-backed commercialization pipeline.
- Buyers
- AGIC Capital
- Targets
- Eulitha AG
- Industry
- Manufacturing
- Location
- Aargau, Switzerland
- Transaction Type
- Growth capital
Explore More
Related Acquisitions
-
AGIC Capital Makes Growth Equity Investment in AP Technologies
August 10, 2023
Medical Devices
AGIC Capital completed a growth equity investment in Singapore-based AP Technologies, a contract manufacturer specializing in precision medical tubing and catheter assemblies. AGIC will partner with AP Tech's founders and management to accelerate global growth and bolster the company's technological capabilities; the deal is AGIC's first transaction in Asia with Fund II.
-
AGIC Capital Acquires Majority Stake in Pure Trade
July 28, 2023
Manufacturing
AGIC Capital acquired a majority stake in Pure Trade from Sparring Capital, the management team, and founders. The existing Pure Trade management team (including CEO Stéfane Ladous) will reinvest and remain in place as AGIC supports geographic expansion (notably US and APAC), ESG and digitalization initiatives, and a buy-and-build strategy to broaden the company’s product offering.
-
AGIC Capital Acquires Majority Stake in Grafotronic AB
May 19, 2022
Manufacturing
AGIC Capital has acquired a majority stake in Grafotronic AB, a Swedish manufacturer of roll-to-roll automated manufacturing solutions for the digital label finishing and EV battery markets. The private equity firm said it invested alongside Grafotronic's management to accelerate international growth, expand commercial and operational capabilities, and support product and R&D expansion across Europe, the US and Asia.
-
Ampersand Capital Partners Makes Growth Investment in Vibalogics GmbH
May 29, 2019
Biotechnology
Ampersand Capital Partners has made a growth equity investment in Vibalogics GmbH, a German CDMO specializing in development and GMP manufacturing of complex viral products. The investment will fund expansion of Vibalogics' process development and manufacturing capabilities and support broader growth in the U.S. and European markets.
-
H.I.G. Capital Acquires ITH Group Limited
June 13, 2025
Healthcare Services
H.I.G. Capital (via an affiliate) has completed the acquisition of ITH Group Limited, a UK-based provider of aseptic pharmaceutical compounding services. Financial terms were not disclosed; ITH's founders Adam Bloom and Karen Hamling will remain in management as H.I.G. supports organic growth and increased production capacity.
-
Catalyst Global Financial Group Raises Growth Investment From Aquiline
January 7, 2025
Financial Services
Catalyst Global Financial Group, an international financial services and technology firm offering fund administration and client accounting services, announced a growth investment from Aquiline (subject to CIMA approval). The capital injection is intended to support scaling, investment in people and technology, and expansion of Catalyst’s market reach.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.